Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
6 price targets
|
0
%
|
|
|
804
Nuvation Bio
NUVB
$3.08B
|
19%
upside
7 price targets
|
0
%
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
11 price targets
|
0
%
|
|
|
|
19%
upside
4 price targets
|
0
%
|
|
|
|
19%
upside
11 price targets
|
0
%
|
|
|
|
19%
upside
9 price targets
|
0
%
|
|
|
|
19%
upside
10 price targets
|
0
%
|
|
|
811
Dianthus Therapeutics
DNTH
$1.79B
|
19%
upside
3 price targets
|
0
%
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
4 price targets
|
0
%
|
|
|
|
19%
upside
12 price targets
|
0
%
|
|
|
|
19%
upside
7 price targets
|
0
%
|
|
|
|
19%
upside
4 price targets
|
0
%
|
|
|
|
19%
upside
11 price targets
|
0
%
|
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
4 price targets
|
0
%
|
|
|
|
19%
upside
33 price targets
|
0
%
|
|
|
|
19%
upside
3 price targets
|
0
%
|
|
|
|
19%
upside
10 price targets
|
0
%
|
|
|
|
19%
upside
5 price targets
|
0
%
|
|